Monday, July 4, 2022

Tag: ACT

Regenerative Medicine Back on Fast Track

After decades of frustratingly slow progress, regenerative medicine is buoyed by optimism. After decades of controversy and frustratingly slow progress, the stem cell field seems...

Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?

Given that the firm with the most money has just quit, questions about how to succeed are rampant. Geron, a pioneer in stem cell research...